Reversal agents to improve safety in patients treated with antiplatelet P2Y12 inhibitors.

26 August 2022 (08:30 - 08:45)
Organised by:
Congress Presentation Part of: Problem-solving in antiplatelet therapy and anticoagulation Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022